SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-13-000041
Filing Date
2013-11-13
Accepted
2013-11-12 18:10:29
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20130930x10q.htm 10-Q 1445837
8 EX-31.1 supn-20130930ex31195cb30.htm EX-31.1 14025
9 EX-31.2 supn-20130930ex3125acac5.htm EX-31.2 14802
10 EX-32.1 supn-20130930ex321db94f0.htm EX-32.1 10629
11 EX-32.2 supn-20130930ex32220cfc7.htm EX-32.2 9342
  Complete submission text file 0001356576-13-000041.txt   7568496

Data Files

Seq Description Document Type Size
2 EX-101.CAL supn-20130930_cal.xml EX-101.CAL 51970
3 EX-101.DEF supn-20130930_def.xml EX-101.DEF 69453
4 EX-101.INS supn-20130930.xml EX-101.INS 1293090
5 EX-101.LAB supn-20130930_lab.xml EX-101.LAB 330690
6 EX-101.PRE supn-20130930_pre.xml EX-101.PRE 223967
7 EX-101.SCH supn-20130930.xsd EX-101.SCH 36267
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 131211764
SIC: 2834 Pharmaceutical Preparations